Fuji Biomedix to Acquire 55% Stake in Seishin Works.Tokyo Tokyo (tō`kēō), city (1990 pop. 8,163,573), capital of Japan and of Tokyo prefecture, E central Honshu, at the head of Tokyo Bay. , Japan, Apr 19, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Fuji Biomedix announced on April 18 that the company has decided to acquire a 55% stake in Seishin Works, making Seishin Works one of its subsidiaries. Seichin Works is a company operating cosmetic cosmetic /cos·met·ic/ (koz-met´ik) 1. pertaining to cosmesis. 2. a beautifying substance or preparation. cos·met·ic n. and plastic surgery clinics in seven major cities across Japan. Specifically, Fuji Biomedix will collaborate with Seishi Works in clinical trials and development of drugs and health foods. Through collaboration Working together on a project. See collaborative software. , Fuji Biomedix aims to strengthen its presence in the anti-aging business. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion